| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/14/2006 | WO2006081074A3 Charge neutralization of polyion complexes |
| 09/14/2006 | WO2006080842A3 Oral vaccines for fish |
| 09/14/2006 | WO2006078268A3 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 09/14/2006 | WO2006075172A3 Methods for identifying compounds capable of modulating cftr/ck2 interaction and/or cftr phosphorylation by ck2 |
| 09/14/2006 | WO2006071776A3 Ligation-based rna amplification |
| 09/14/2006 | WO2006069812A3 Retrotransposon inhibition in therapy |
| 09/14/2006 | WO2006068987A3 Uses of il-23 antagonists in the treatment of diabetes mellitus |
| 09/14/2006 | WO2006066439A3 Rna-sequence or nucleoside/nucleotide analogues and method for producing the analogues |
| 09/14/2006 | WO2006066203A3 Small interfering rna (sirna) molecules for modulating superoxide dismutase (sod) |
| 09/14/2006 | WO2006065582A3 Muteins of fibroblast growth factor 21 |
| 09/14/2006 | WO2006061242A3 Use of pta peptides for stratification of individuals having cancer |
| 09/14/2006 | WO2006060062A3 Trichoderma reesei glucoamylase and homologs thereof |
| 09/14/2006 | WO2006056885A3 Igf-1 isoforms |
| 09/14/2006 | WO2006053169A3 Pm29 and lea3 promoters and use in expression of transgenic genes in plants |
| 09/14/2006 | WO2006047589A3 Improved alanine 2,3-aminomutases and related polynucleotides |
| 09/14/2006 | WO2006047311A3 Cloning of the retinoic acid inducible gene-1 promoter and uses thereof |
| 09/14/2006 | WO2006039258A3 Human antibodies against parathyroid hormone |
| 09/14/2006 | WO2006023210A3 Gp132: mehods and compositions for treating cancer |
| 09/14/2006 | WO2006020684A3 Methods of regulating differentiation and treating of multiple myeloma |
| 09/14/2006 | WO2006020184A3 Retinal dystrophin transgene and methods of use thereof |
| 09/14/2006 | WO2006017741A3 Radiation inducible iex-1 promoter |
| 09/14/2006 | WO2006008484A3 Detection of cellular stress |
| 09/14/2006 | WO2005115136A3 Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases |
| 09/14/2006 | WO2005105152A3 Lipids, lipid complexes and use thereof |
| 09/14/2006 | WO2005086875A3 A humanized anti-cea t84.66 antibody and uses thereof |
| 09/14/2006 | WO2005086667A3 High efficiency peptide production in plant cells |
| 09/14/2006 | WO2005067583A8 Immunoliposome-nucleic acid amplication (ilnaa) assay |
| 09/14/2006 | WO2005046314A3 Tomatoes having altered acid invertase activity due to non-transgenic alterations in acid invertase genes |
| 09/14/2006 | WO2005037392A3 Method for the dissociation of the extracellular haemoglobin molecule of arenicola marina and the characterisation of the protein chains forming the molecule and the nucleotide sequences coding for said protein chains |
| 09/14/2006 | WO2005021583A8 METHODS FOR IDENTIFYING, TREATING, AND INDUCING INFERTILITY USING SMC1β |
| 09/14/2006 | WO2005007121A3 Mutant interleukin-2(il-2) polypeptides |
| 09/14/2006 | WO2004108066A3 Neuronal regeneration and compound administration methods |
| 09/14/2006 | WO2004075836A3 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| 09/14/2006 | WO2004062619A3 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 09/14/2006 | WO2004050831A3 Compositions, organisms and methodologies employing a novel human kinase |
| 09/14/2006 | WO2004005462A3 Reagents and methods for identifying and modulating expression of tumor senescence genes |
| 09/14/2006 | WO2003095614A3 Cytokine polypeptides |
| 09/14/2006 | WO2003089588A3 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 09/14/2006 | WO2003002721A3 Compositions and methods for inferring a response to a statin |
| 09/14/2006 | US20060206967 Genetic control of flowering |
| 09/14/2006 | US20060206966 High level of activity in monocotyledonous plants; for enhancing stress tolerance of a plant, rice |
| 09/14/2006 | US20060206965 Combination of genes for the regulation of the induction of flowering in useful and ornamental plants |
| 09/14/2006 | US20060206964 Method for enhancing cellulose and modifying lignin biosynthesis in plants |
| 09/14/2006 | US20060206963 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 09/14/2006 | US20060206962 Preparation of deallergenized proteins and permuteins |
| 09/14/2006 | US20060206961 Use of genes for increasing the oil content in plants |
| 09/14/2006 | US20060206960 Higher plant cytosolic er-based glycerol-3-phosphate acyltransferase genes |
| 09/14/2006 | US20060206959 Genetic engineering to modify genes in order to result in an ineffective target of the post-trascriptional gene silencing induced by geminiviruses; mutated polynucleotide sequence of a tomato infecting geminivirus |
| 09/14/2006 | US20060206958 Transforming a plant or plant cell with a nucleotide sequence operably linked to a promoter active in plant cells encoding an NRC1 protein and forming a transgenic plant; family Solanaceae, genus Solanum; cells, seeds, fruits |
| 09/14/2006 | US20060206957 Converting farnesyl-pyrophosphate to patchoulol, gamma -curcumene and other germacrane-type sesquiterpenes; vectors; host cells |
| 09/14/2006 | US20060206956 Triticum aestivium plant; glyphosate herbicide resistant due to the expression of naturally-occurring genes |
| 09/14/2006 | US20060206955 Natural herbicide resistance in wheat |
| 09/14/2006 | US20060206954 Polynucleotide that expresses a polypeptide having AP2 domain; plant transcription regulators contain a DNA binding domain called the AP2 domain; use in genetic engineering of plants, host cells |
| 09/14/2006 | US20060206953 Derivation of embryonic stem cells |
| 09/14/2006 | US20060206950 In vivo imaging of e2f-fegulated bioluminescent proteins |
| 09/14/2006 | US20060206949 Custom-made meganuclease and use thereof |
| 09/14/2006 | US20060205934 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 09/14/2006 | US20060205926 Human growth hormone domains |
| 09/14/2006 | US20060205925 Inhibits hemolysis by interacting with the plasma proteins clusterin; histidine rich glycoprotein (HRG); Streptococcal Inhibitor of Complement-mediated lysis |
| 09/14/2006 | US20060205924 Spliced variants of lgr6 |
| 09/14/2006 | US20060205688 Method of modulating epithelial cell activity by modulating the functional levels of sphingosine kinase |
| 09/14/2006 | US20060205668 For therapy of spinal cord injury or stroke, by overcoming the inhibitory effects of myelin on axonal regeneration |
| 09/14/2006 | US20060205656 P-superfamily conopeptides |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205653 protein that potentiates toxin activity of a Class A toxin complex protein against an insect; insecticides |
| 09/14/2006 | US20060205640 Cationic peptide that inhibits the growth of both grampositive and/or gramnegative bacteria; isolated from the hemocytes of the sea squirt; can be used to treat antibiotic resistant tuberculosis, pneumonia, and urinary pathologies |
| 09/14/2006 | US20060205081 Use of methyltransferase inhibitors to enhance transgene expression |
| 09/14/2006 | US20060205080 Formulations for therapeutic viruses having enhanced storage stability |
| 09/14/2006 | US20060205079 Amplifiable adeno-associated virus (AAV) packaging cassettes for the production of recombinant AAV vectors |
| 09/14/2006 | US20060205078 Induction of RNA Interference by Aberrant RNA |
| 09/14/2006 | US20060205077 Targeted transgenesis using the rosa26 locus |
| 09/14/2006 | US20060205070 HIV TEV compositions and methods of use |
| 09/14/2006 | US20060205068 Useful in identifying and designing novel Bt toxin receptor ligands including novel insecticidal toxins; manipulating Bt toxin susceptibility in plant pests |
| 09/14/2006 | US20060205067 Vector that produces a fusion protein of an antigen with a Listerial truncated ActA protein; use making vaccines |
| 09/14/2006 | US20060205064 Reaction vessel, reaction apparatus and reaction solution temperature control method |
| 09/14/2006 | US20060205052 Bardet-Biedl susceptibility gene and uses thereof |
| 09/14/2006 | US20060205049 Method for the production of resveratrol in cell cultures |
| 09/14/2006 | US20060205048 Process for producing succinic acid |
| 09/14/2006 | US20060205046 Nucleotide sequences which code for the zwa1 gene |
| 09/14/2006 | US20060205045 Which produces N-alkyl-L-alanine from pyruvic acid and alkylamine or dialkylamine using NADPH and/or NADH as coenzyme; biosynthesis |
| 09/14/2006 | US20060205044 Strains in which an aspartate semialdehyde dehydrogenase gene is operably associated with at least one non-native promoter, non-native ribosome binding site, or both; novel plasmid |
| 09/14/2006 | US20060205043 Method for producing target substance by fermentation |
| 09/14/2006 | US20060205041 Recombinant bovine thrombin |
| 09/14/2006 | US20060205038 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 09/14/2006 | US20060205033 Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 09/14/2006 | US20060205031 Newly identified cholinephosphotransferases and ethanolaminephosphotransferases |
| 09/14/2006 | US20060205030 Hydantoinase; carbamylases; nutraceuticals; animal feeds/husbandry |
| 09/14/2006 | US20060205021 Mammalian IAP gene family, primers, probes and detection methods |
| 09/14/2006 | US20060205019 Methods and compositions for directed gene assembly |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060205017 Microorganism genomics, compositions and methods related thereto |
| 09/14/2006 | US20060205016 Protein a based binding domains with desirable activities |
| 09/14/2006 | US20060205006 PCR method and related apparatus |
| 09/14/2006 | US20060205004 Reversible association of nucleic acid with a carboxylated substrate |
| 09/14/2006 | US20060205000 Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction |
| 09/14/2006 | US20060204996 Method of designing primer and probe sets, primer and probe set designed by the method, kit comprising the sets, computer readable medium recorded thereon program to execute the method, and method of identifying target sequence using the sets |
| 09/14/2006 | US20060204995 Method of designing probe set, probe set designed by the method, microarray comprising the probe set, computer readable medium recorded thereon program to execute the method, and method of identifying target sequence using the probe set |
| 09/14/2006 | US20060204987 Applications with and methods for producing selected interstrand cross-links in nucleic acids |
| 09/14/2006 | US20060204983 Binding assay using binding agents with tail groups |
| 09/14/2006 | US20060204982 Novel compositions and methods for cancer |